Multibagger Penny Stock Below Rs 50: ADAM Consumer Health Successfully Maintains URAC Certification; Reinforces Commitment to Quality and Excellence
DSIJ Intelligence-1

Multibagger Penny Stock Below Rs 50: ADAM Consumer Health Successfully Maintains URAC Certification; Reinforces Commitment to Quality and Excellence

From Rs 0.82 to Rs 45.55 per share, the stock gave multibagger returns of 5,455 per cent in 3 years.

Eraaya Lifespaces Limited announced that its subsidiary, A.D.A.M. Consumer Health (ADAM), a part of the Ebix Group, has successfully maintained its URAC Health Content Provider Certification. This significant achievement, despite a year of organisational changes, underscores ADAM's unwavering commitment to delivering credible, high-quality, and trusted health information to consumers. The certification ensures that ADAM's products meet international benchmarks for transparency, editorial integrity, and patient empowerment, reflecting the team's dedication to quality standards and consumer trust in health education.

In addition to this quality milestone, A.D.A.M. Consumer Health demonstrated strong financial performance, reporting a total revenue of approximately USD 7.7 million in FY 2023–24. This performance highlights its continued leadership in health education solutions, medical illustrations, and evidence-based content development. With a diverse global client base spanning healthcare providers, educational institutions, insurance firms, and digital platforms, ADAM remains a crucial component of the Ebix Group’s healthcare content and e-learning vertical, further reinforcing its position as a trusted global content leader as Eraaya Lifespaces expands its presence in health and wellness.

DSIJ’s 'multibagger Pick’ service recommends well researched multibagger stocks with High Returns potential. If this interests you, do download the service details here.

About the Company

Eraaya Lifespaces, a lifestyle and hospitality company focused on luxury, innovation, and technology, is expanding its global footprint and offerings through the strategic acquisition of Ebix Inc. USA and its worldwide subsidiaries. This move significantly broadens Eraaya's scope beyond its core business of creating immersive cultural experiences, as Ebix is a global leader in software and e-commerce solutions across insurance, financial services, travel, healthcare, and e-learning. By integrating Ebix's expertise in areas like advanced insurance exchanges and SaaS solutions, Eraaya aims to drive transformative innovation and redefine the future of business in interconnected global markets.

In its Quarterly Results (Q4FY25), the company reported net sales of Rs 1.88 crore and a net loss of Rs 6 crore while in its half-yearly results (H2FY25), the company reported net sales of Rs 15.32 crore and a net loss of Rs 26.85 crore. Looking at its annual results (FY25), the company reported net sales of Rs 22.32 crore and a net profit of Rs 25.87 crore.

The company has a market capitalisation of over Rs 800 crore and a 285 per cent 3-year stock price CAGR. From Rs 0.82 to Rs 45.55 per share, the stock gave multibagger returns of 5,455 per cent in 3 years. The promoters of the company bought 14 lakh shares in Q4FY25 compared to Q3FY25. As of March 2025, the company's promoters own 35.61 per cent stake, FIIs own 22.52 per cent, DIIs own 1.81 per cent and the rest 40.06 per cent stake is owned by the public.

Disclaimer: The article is for informational purposes only and not investment advice. 

Previous Article Dalal Street Slips After Early Gains; HDB Financial Debuts With Strong Premium
Next Article Jhunjhunwala’s Backed Company Announces Transformational Partnership with Western Washington Medical Group
Print
232 Rate this article:
4.7
Please login or register to post comments.
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR